Compass Therapeutics (CMPX) Change in Account Payables (2019 - 2026)
Compass Therapeutics (CMPX) posted Change in Account Payables of -$679000.0 for Q1 2026, up 55.03% sequentially from -$1.5 million in Q4 2025, and down 1.04% YoY from -$686147.4 in Q1 2025.
Compass Therapeutics (CMPX) Change in Account Payables (2019 - 2026) Analysis & Trends
Compass Therapeutics has reported Change in Account Payables for 8 years, with the latest figure at -$679000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 1.04% year-over-year to -$679000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$671000.0 (down 192.81% YoY) and the FY2025 annual result came in at -$664000.0, up 63.93% from the prior year.
- Change in Account Payables improved to -$679000.0 in Q1 2026 per CMPX's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $6.2 million in Q2 2022 and troughed at -$3.7 million in Q3 2022.
- A 5-year average of $2294.1 and a median of -$232000.0 in 2024 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 62200.0% in 2022, down 1295.47% in 2022.
- Over 5 years, Change in Account Payables stood at $621000.0 in 2022, then soared by 187.28% to $1.8 million in 2023, then declined by 27.75% to $1.3 million in 2024, then plunged by 217.15% to -$1.5 million in 2025, then jumped by 55.03% to -$679000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$679000.0, -$1.5 million, and $500000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | -679,000.00 |
| Mar 31, 2026 | -679,000.00 |
| Dec 31, 2025 | -1.51 Mn |
| Dec 31, 2025 | -1.51 Mn |
| Sep 30, 2025 | 500,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | -672,000.00 |
| Mar 31, 2025 | -672,000.00 |
| Dec 31, 2024 | 1.29 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | -232,000.00 |
| Sep 30, 2024 | -232,000.00 |
| Jun 30, 2024 | 338,000.00 |
| Jun 30, 2024 | 338,000.00 |
| Mar 31, 2024 | -3.24 Mn |
| Mar 31, 2024 | -3.24 Mn |